ArticleDermatology and therapy2017

Topical Treatment of Rosacea with Ivermectin Inhibits Gene Expression of Cathelicidin Innate Immune Mediators, LL-37 and KLK5, in Reconstructed and Ex Vivo Skin Models.

Séverine Thibaut de Ménonville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.